lacosamide

Generic: lacosamide

Labeler: msn laboratories private limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lacosamide
Generic Name lacosamide
Labeler msn laboratories private limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

lacosamide 50 mg/1

Manufacturer
MSN LABORATORIES PRIVATE LIMITED

Identifiers & Regulatory

Product NDC 69539-025
Product ID 69539-025_421cfdea-11a0-4fd7-8b8f-79711f1e5f89
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204921
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2022-03-19

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69539025
Hyphenated Format 69539-025

Supplemental Identifiers

RxCUI
809987 809992 809996 810000
UPC
0369539025602 0369539026609 0369539027606 0369539028603
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lacosamide (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number ANDA204921 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 500 TABLET, FILM COATED in 1 BOTTLE (69539-025-05)
  • 60 TABLET, FILM COATED in 1 BOTTLE (69539-025-60)
source: ndc

Packages (2)

69539-025-05 500 TABLET, FILM COATED in 1 BOTTLE (69539-025-05) 69539-025-60 60 TABLET, FILM COATED in 1 BOTTLE (69539-025-60)

Ingredients (1)

lacosamide (50 mg/1)

Linked Drug Pages (1)

lacosamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "421cfdea-11a0-4fd7-8b8f-79711f1e5f89", "openfda": {"nui": ["N0000008486"], "upc": ["0369539025602", "0369539026609", "0369539027606", "0369539028603"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["0ae4e2d1-305d-4045-95da-cfe7c2d8b435"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["MSN LABORATORIES PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (69539-025-05)", "package_ndc": "69539-025-05", "marketing_start_date": "20220319"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (69539-025-60)", "package_ndc": "69539-025-60", "marketing_start_date": "20220319"}], "brand_name": "lacosamide", "product_id": "69539-025_421cfdea-11a0-4fd7-8b8f-79711f1e5f89", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69539-025", "dea_schedule": "CV", "generic_name": "lacosamide", "labeler_name": "MSN LABORATORIES PRIVATE LIMITED", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "50 mg/1"}], "application_number": "ANDA204921", "marketing_category": "ANDA", "marketing_start_date": "20220319", "listing_expiration_date": "20261231"}